Kshama Mehta
Overview
Explore the profile of Kshama Mehta including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
719
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mehta K, Hussein W, Leuther K, Fegler A, Schiller B, Bennett P
J Ren Care
. 2024 May;
50(4):365-375.
PMID: 38734873
Background And Objective: Starting dialysis is a life-changing transition for people living with kidney disease. People feel overwhelmed with diet changes, medications and surgical interventions, and often experience high levels...
2.
Tao J, Mariani L, Eddy S, Maecker H, Kambham N, Mehta K, et al.
Clin J Am Soc Nephrol
. 2020 May;
15(7):973-982.
PMID: 32354727
Background And Objectives: IgA nephropathy is the most common primary glomerular disease in the world. Marked by mesangial inflammation and proliferation, it generally leads to progressive kidney fibrosis. As the...
3.
Tao J, Mariani L, Eddy S, Maecker H, Kambham N, Mehta K, et al.
Kidney Int
. 2018 Aug;
94(4):795-808.
PMID: 30093081
Focal segmental glomerular sclerosis (FSGS) is a devastating disease with limited treatment options and poor prognosis. Activated JAK-STAT signaling has been implicated in other kidney diseases. Since new technologies allow...
4.
Lafayette R, Canetta P, Rovin B, Appel G, Novak J, Nath K, et al.
J Am Soc Nephrol
. 2016 Nov;
28(4):1306-1313.
PMID: 27821627
IgA nephropathy frequently leads to progressive CKD. Although interest surrounds use of immunosuppressive agents added to standard therapy, several recent studies have questioned efficacy of these agents. Depleting antibody-producing B...
5.
Nargund P, Kambham N, Mehta K, Lafayette R
Clin Nephrol
. 2015 Oct;
84(6):323-30.
PMID: 26445002
Background: A recent classification of membranoproliferative glomerulonephritis (MPGN) utilizes the presence of immunoglobulin and complements to simplify diagnosis and point towards disease etiology. Here, we evaluate a historic cohort of...
6.
Hogan J, Bomback A, Mehta K, Canetta P, Rao M, Appel G, et al.
Clin J Am Soc Nephrol
. 2013 Sep;
8(12):2072-81.
PMID: 24009220
Background And Objectives: Adrenocorticotropic hormone (ACTH) has shown efficacy as primary and secondary therapy for nephrotic syndrome due to membranous nephropathy. The data on using ACTH to treat idiopathic FSGS...
7.
Zhu Y, Colak T, Shenoy M, Liu L, Mehta K, Pai R, et al.
Mol Pain
. 2012 Sep;
8:65.
PMID: 22963239
Background: Transforming growth factor beta (TGFβ) is upregulated in chronic inflammation, where it plays a key role in wound healing and promoting fibrosis. However, little is known about the peripheral...
8.
Zhu Y, Mehta K, Li C, Xu G, Liu L, Colak T, et al.
Am J Physiol Gastrointest Liver Physiol
. 2011 Nov;
302(1):G176-81.
PMID: 22038828
We have previously shown that pancreatic sensory neurons in rats with chronic pancreatitis (CP) display increased excitability associated with a decrease in transient inactivating potassium currents (I(A)), thus accounting in...
9.
Guo J, Pasricha N, Shenoy M, Liu L, Mehta K, Pasricha P
Surg Endosc
. 2011 Oct;
26(3):747-53.
PMID: 22002201
Background: Natural orifice translumenal endoscopic surgery (NOTES) and laparoendoscopic single-port surgery (LESS) are emerging approaches to abdominal surgery that have been advocated as potentially causing fewer physiologic derangements and less...
10.
Liu L, Li Q, Sapolsky R, Liao M, Mehta K, Bhargava A, et al.
PLoS One
. 2011 May;
6(5):e19498.
PMID: 21589865
Aims: A disturbance of the brain-gut axis is a prominent feature in functional bowel disorders (such as irritable bowel syndrome and functional dyspepsia) and psychological abnormalities are often implicated in...